UY30811A1 - Derivados de amina, composiciones conteniéndolos, procesos de preparacion, compuestos intermedios y aplicaciones - Google Patents
Derivados de amina, composiciones conteniéndolos, procesos de preparacion, compuestos intermedios y aplicacionesInfo
- Publication number
- UY30811A1 UY30811A1 UY30811A UY30811A UY30811A1 UY 30811 A1 UY30811 A1 UY 30811A1 UY 30811 A UY30811 A UY 30811A UY 30811 A UY30811 A UY 30811A UY 30811 A1 UY30811 A1 UY 30811A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compositions containing
- amina
- derivatives
- applications
- intermediate compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La presente invencion proporciona un compuesto de formula I en donde K, Ar, R2, R3, R4, R5, R4?? , R5??, R6??, R7??, A, D, m y E son como se definen en la memoria descriptiva, procedimientos para la preparacion de los mismos, composiciones farmacéuticas que los contienen y su utilizacion en terapia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87095606P | 2006-12-20 | 2006-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30811A1 true UY30811A1 (es) | 2008-07-31 |
Family
ID=39048968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30811A UY30811A1 (es) | 2006-12-20 | 2007-12-19 | Derivados de amina, composiciones conteniéndolos, procesos de preparacion, compuestos intermedios y aplicaciones |
Country Status (19)
Country | Link |
---|---|
US (2) | US20120142646A1 (es) |
EP (1) | EP2094646A1 (es) |
JP (1) | JP2010513439A (es) |
KR (1) | KR20090094149A (es) |
CN (1) | CN101636379A (es) |
AR (1) | AR064636A1 (es) |
AU (1) | AU2007336074B2 (es) |
BR (1) | BRPI0722095A2 (es) |
CA (1) | CA2672792A1 (es) |
CL (1) | CL2007003754A1 (es) |
CO (1) | CO6210822A2 (es) |
EC (1) | ECSP099425A (es) |
MX (1) | MX2009006010A (es) |
NO (1) | NO20092690L (es) |
PE (1) | PE20081388A1 (es) |
RU (1) | RU2472783C2 (es) |
TW (1) | TW200835686A (es) |
UY (1) | UY30811A1 (es) |
WO (1) | WO2008075025A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
SI2242759T1 (sl) | 2008-02-06 | 2013-01-31 | Astrazeneca Ab | Spojine |
BRPI0915428A2 (pt) | 2008-06-18 | 2015-11-03 | Astrazeneca Ab | derivados de benzoxazinona atuando como agonistas adrenorreceptor beta2 para o tratamento de distúrbios respiratórios |
EP2303266A4 (en) * | 2008-06-20 | 2015-01-21 | Astrazeneca Ab | PHARMACEUTICAL COMPOSITION COMPRISING A 4-HYDROXY-2-OXO-2,3-DIHYDRO-1,3-BENZOTHIAZOL-7-YLE COMPOUND FOR THE MODULATION OF BETA-2-ADRENORECEPTOR ACTIVITY |
GB0913342D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | Compounds - 801 |
WO2011048409A1 (en) | 2009-10-20 | 2011-04-28 | Astrazeneca Ab | Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
US9598381B2 (en) * | 2014-07-31 | 2017-03-21 | Abbvie Inc. | SMYD2 inhibitors |
CN107188865B (zh) * | 2016-03-14 | 2019-08-27 | 益方生物科技(上海)有限公司 | 苯并噁嗪化合物及其制备方法和用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2653977A (en) * | 1953-09-29 | Chxnx | ||
EP0132267B1 (en) * | 1983-01-21 | 1989-01-18 | FISONS plc | Aromatic amines |
US5648370A (en) * | 1990-11-20 | 1997-07-15 | Astra Pharmaceuticals Limited | 7-(2-aminoethyl) benzothiazolones |
GB9210632D0 (en) * | 1992-05-19 | 1992-07-01 | Fisons Plc | Compounds |
TW356468B (en) * | 1995-09-15 | 1999-04-21 | Astra Pharma Prod | Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same |
US7217722B2 (en) * | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
TWI249515B (en) * | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
GB0217225D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
PE20050130A1 (es) * | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
TW200738658A (en) * | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200740781A (en) * | 2005-08-29 | 2007-11-01 | Astrazeneca Ab | Novel compounds |
TW200745084A (en) * | 2006-03-08 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
-
2007
- 2007-12-19 UY UY30811A patent/UY30811A1/es unknown
- 2007-12-19 BR BRPI0722095-2A2A patent/BRPI0722095A2/pt not_active IP Right Cessation
- 2007-12-19 US US11/959,735 patent/US20120142646A1/en not_active Abandoned
- 2007-12-19 CA CA002672792A patent/CA2672792A1/en not_active Abandoned
- 2007-12-19 JP JP2009542201A patent/JP2010513439A/ja not_active Withdrawn
- 2007-12-19 TW TW096148621A patent/TW200835686A/zh unknown
- 2007-12-19 US US12/519,591 patent/US20100056508A1/en not_active Abandoned
- 2007-12-19 AU AU2007336074A patent/AU2007336074B2/en not_active Ceased
- 2007-12-19 KR KR1020097015072A patent/KR20090094149A/ko not_active Application Discontinuation
- 2007-12-19 CN CN200780051580A patent/CN101636379A/zh active Pending
- 2007-12-19 RU RU2009119912/04A patent/RU2472783C2/ru not_active IP Right Cessation
- 2007-12-19 WO PCT/GB2007/004859 patent/WO2008075025A1/en active Application Filing
- 2007-12-19 MX MX2009006010A patent/MX2009006010A/es active IP Right Grant
- 2007-12-19 EP EP07848596A patent/EP2094646A1/en not_active Withdrawn
- 2007-12-20 CL CL200703754A patent/CL2007003754A1/es unknown
- 2007-12-20 AR ARP070105802A patent/AR064636A1/es not_active Application Discontinuation
-
2008
- 2008-01-02 PE PE2008000006A patent/PE20081388A1/es not_active Application Discontinuation
-
2009
- 2009-05-27 CO CO09054436A patent/CO6210822A2/es not_active Application Discontinuation
- 2009-06-15 EC EC2009009425A patent/ECSP099425A/es unknown
- 2009-07-15 NO NO20092690A patent/NO20092690L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2010513439A (ja) | 2010-04-30 |
WO2008075025A1 (en) | 2008-06-26 |
RU2009119912A (ru) | 2011-01-27 |
TW200835686A (en) | 2008-09-01 |
BRPI0722095A2 (pt) | 2014-04-01 |
MX2009006010A (es) | 2009-06-16 |
AU2007336074B2 (en) | 2011-09-22 |
CO6210822A2 (es) | 2010-10-20 |
US20120142646A1 (en) | 2012-06-07 |
CN101636379A (zh) | 2010-01-27 |
KR20090094149A (ko) | 2009-09-03 |
PE20081388A1 (es) | 2008-11-26 |
AU2007336074A1 (en) | 2008-06-26 |
AR064636A1 (es) | 2009-04-15 |
US20100056508A1 (en) | 2010-03-04 |
NO20092690L (no) | 2009-09-03 |
ECSP099425A (es) | 2009-07-31 |
RU2472783C2 (ru) | 2013-01-20 |
CL2007003754A1 (es) | 2008-08-22 |
EP2094646A1 (en) | 2009-09-02 |
CA2672792A1 (en) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30811A1 (es) | Derivados de amina, composiciones conteniéndolos, procesos de preparacion, compuestos intermedios y aplicaciones | |
UY31524A1 (es) | Nuevos compuestos 010 | |
UY30206A1 (es) | Derivados de diamina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
UY30789A1 (es) | Derivados de adenina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
UY30195A1 (es) | Derivados de fenetanolamina, procedimiento de preparacion, composiciones que los contienen y aplicaciones | |
UY31069A1 (es) | Nuevos derivados de imidazoquinola, composiciones conteniendolos, proceso de preparacion y aplicaciones | |
UY30808A1 (es) | Derivados de benzotiazolonas, composiciones conteniéndolos y aplicaciones | |
UY29795A1 (es) | Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones | |
UY32611A (es) | Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
UY29886A1 (es) | Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones | |
UY29768A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones | |
UY30976A1 (es) | Nuevos derivados de quinolina, composiciones farmaccuticas que los contienen, procesos de preparacion y aplicaciones. | |
UY29360A1 (es) | Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones. | |
UY30327A1 (es) | Nuevos compuestos ii | |
UY31260A1 (es) | Compuestos de pirazol, composiciones conteniendolos y aplicaciones. | |
EA201001205A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
UY31183A1 (es) | Derivados de pirazinona y procesos para su preparación | |
ECSP10010272A (es) | Derivados bis-(sulfonilamino) para uso en terapia | |
UY30328A1 (es) | Derivados de 2-piridona, procesos de preparacion, composiciones conteniéndolos y aplicaciones. | |
CR10148A (es) | Derivados de las benzamidas y heteroarenos | |
DK2134691T3 (da) | Quinolinonderivativer som parp- og tank-inhibitorer | |
UY30748A1 (es) | Compuesto0s novedosos | |
UY29767A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones | |
UY31048A1 (es) | Nuevos compuestos de pirimidina y usos de los mismos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DESI | Application deemed to be withdrawn |
Effective date: 20120611 |